Zhejiang Garden Biopharmaceutical Reports H1 2026 Net Profits of RMB 132 Million, Down 18.34% YoY

Zhejiang NHU Achieves Net Profits of RMB 4.011 Billion in H1 2026, Up 11.31% YoY

Meihua Holdings: H1 2026 Net Profits Drop 62.56% YoY to RMB 662 Million

USITC Determines Chinese L-Lysine Injure U.S. Industry

What the “Niu Lai” Phenomenon Reveals About the Outlook for Lysine, Methionine, and Vitamin E Markets

China’s Amino Acid Market: Methionine Prices Continue to Weaken; Threonine and Tryptophan Edge Higher; Downstream Order Volume Remains Average

China’s Vitamin Market Consolidates Narrowly Amid Stronger Wait-and-See Sentiment; VA and VE Prices Firm Up

China’s Vitamin Market Consolidates with a Weak Bias Amid Downstream Hand-to-Mouth Buying; VE Prices Firm; European Market Keeps Drifting Lower

Dicalcium Phosphate Market Continues to Weaken; Sodium Bicarbonate Holds Steady; Whey Powder Edges Higher

Chinese End Users Maintain Cautious Restocking as Methionine Extends Downtrend but Tryptophan Edges Higher; European Q4 Buying Sentiment Diverges